Metabolic syndrome, central obesity and insulin resistance are associated with adverse pathological features in postmenopausal breast cancer. (Q43147444)
Jump to navigation
Jump to search
scientific article published on 26 February 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Metabolic syndrome, central obesity and insulin resistance are associated with adverse pathological features in postmenopausal breast cancer. |
scientific article published on 26 February 2010 |
Statements
Metabolic syndrome, central obesity and insulin resistance are associated with adverse pathological features in postmenopausal breast cancer (English)
L A Healy
D Ennis
V Crowley
T Boyle
M J Kennedy
26 February 2010